Patient: 91F
-
Dx: Bilateral pneumonia
-
PMH: CHF, Afib, CKD, TIA, HTN
-
Status: DNR
-
Neuro: A&O x4
-
Resp: 2L NC baseline, BiPAP at HS
-
CV: Stable
-
GI/GU: Purewick for incontinence, bedpan for BM
-
Mobility: Bedrest, requires 1–2 assist with walker
-
Diet: 2g sodium
-
Access: None noted
-
Plan: Discharged home with daughter today
Patient: 46M
-
Dx: Colitis, fevers
-
PMH: HIV/AIDS, diverticulitis, OSA (CPAP HS), GERD, HLD
-
Status: Full code
-
Neuro: A&O x4
-
Resp: RA
-
CV: Stable
-
GI: Abdominal pain, suspected C. diff; contact isolation
-
Mobility: Ambulatory
-
Access: Not specified
-
Pain/Tx: Morphine q3h, Dilaudid q4h, Tylenol q6h
-
Plan: Continue isolation, pain management, monitor for C. diff results
-
Dx: Symptomatic anemia, chest pain
-
PMH: HLD, HTN, CAD w/ stents, Afib, DM
-
Status: DNR
-
Neuro: A&O x4, occasional confusion
-
Resp: RA
-
CV: Stable
-
GI: Persistent diarrhea; s/p EGD; NPO → advanced to clears
-
Heme: s/p 2U PRBC (Hgb improved from 4.6 → 8.7 on 10/18)
-
Mobility: Bedrest, SBA x1
-
Access: #22 L forearm, difficult stick
-
Diet: Clears
-
Meds: Ferrous gluconate, Protonix, Miralax, sliding scale insulin
-
Plan: Monitor diarrhea, repeat H/H, supportive care
-
Dx: LLL pneumonia
-
PMH: CVA, HTN, DVT, CKD, CHF, COPD, IVC filter
-
Status: Full
-
Resp: 2L NC, CPAP at bedside
-
CV: Stable
-
Mobility: Bedrest at baseline
-
Access: #20 Right AC
-
Meds: Prednisone, Isosorbide, Metoprolol, Lasix, Zyrtec, Lipitor, Nystatin powder, Symbicort, ASA
-
Tests: CT chest, bedside CXR today
-
Plan: Discharge canceled today, continue medical management
-
Patient: 34M
-
Dx: Sepsis
-
PMH: Quadriplegia, respiratory failure, brain injury, cardiac arrest, anemia
-
Status: Full code
-
Neuro: Nonverbal baseline
-
Resp: Trached & capped, continuous monitoring, tachycardic on tele
-
Isolation: MDRO precautions
-
GI: NPO; PEG tube feeds (2 cal @ 55/hr)
-
GU: Chronic Foley
-
Access: R midline
-
Other: Bilateral wrist mitten restraints (non-violent)
-
Plan: Continue PEG feeds, monitor sepsis parameters, supportive care.
No comments:
Post a Comment